Clinical Trials

240 enrolled

Peripheral Nervous System Diseases

NCT07476729 2026-03-17

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

750 enrolled

Lymphoid

Burkitt Lymphoma

NCT07477808 2026-03-17

Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer

116 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07472868 2026-03-16

MEND-IT II

394 enrolled

Pathologic Complete Response

NCT07469046 2026-03-13

VAH vs VA in Newly Diagnosed Elderly AML

308 enrolled

Leukemia, Myeloid, Acute

NCT07463651 2026-03-11

TROPHY-15

594 enrolled

Leukemia, Myeloid, Acute

NCT07461675 2026-03-10

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

30 enrolled

Carcinoma, Hepatocellular

NCT07453472 2026-03-06

PDT CALCI HOL

166 enrolled

Leukoplakia, Oral

NCT07452458 2026-03-05

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

398 enrolled

Glioblastoma

NCT07407140 2026-03-02

VAG-3+7-G

300 enrolled

Leukemia, Myeloid, Acute

NCT07441681 2026-03-02

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

454 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT06959433 2026-02-27

Lu-177 PSMA Treatment in Cell Renal Carcinoma

20 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07436741 2026-02-27

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

106 enrolled

Pancreatic cancer, adult

NCT07432087 2026-02-25

Camrelizumab Combined With EGFR Monoclonal Antibody or Chemotherapy for Perioperative Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

246 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07432178 2026-02-25

CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）

2,288 enrolled

Breast Neoplasms

NCT06446557 2026-02-20

DIAMOND

408 enrolled

Colonic Neoplasms

NCT06448286 2026-02-19

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

60 enrolled

Glioblastoma

NCT06123156 2026-02-18

RECTIL

188 enrolled

Rectal Neoplasms

NCT06822751 2026-02-17

FOMUTI

138 enrolled

Endocrine

Cystitis, Prostatitis, Urinary Tract Infections, Multiple Endocrine Neoplasia Type 1

NCT07411274 2026-02-13

Ultrasound-Guided vs. Conventional Scalp Block for Postoperative Analgesia in Pediatric Supratentorial Tumor Surgeries

74 enrolled

Pain, Postoperative

NCT07113275 2026-02-12

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in High-Risk Locally Advanced Rectal Cancer

435 enrolled

Rectal Neoplasms

NCT07407517 2026-02-12

POLARIS

904 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07407660 2026-02-12

Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax

250 enrolled

Leukemia, Myeloid, Acute

NCT07385365 2026-02-11

A Study of Postoperative Regional Nodal Radiotherapy in Intermediate-risk Breast Cancer

3,142 enrolled

Breast Neoplasms

NCT07402538 2026-02-11

Surgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced Oral and HPV-unrelated Oropharyngeal Squamous Cell Carcinoma

184 enrolled

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07400523 2026-02-10

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

446 enrolled

Breast Neoplasms

NCT07382687 2026-02-03

Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent Advanced HR+/HER2- Breast Cancer With SNF4 Subtype

248 enrolled

Breast Neoplasms

NCT07385079 2026-02-03

Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma

412 enrolled

Nasopharyngeal Neoplasms

NCT07381660 2026-02-02

SBRT Versus Surgical Resection for Small HCC

312 enrolled

Carcinoma, Hepatocellular

NCT06952621 2026-01-30

TD-NEOE3V3

390 enrolled

Esophageal Squamous Cell Carcinoma

NCT07376304 2026-01-29

BrainUS-AI

100 enrolled

Brain Neoplasms, Glioblastoma, Glioma

NCT07371897 2026-01-28

SHINE

154 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07372144 2026-01-28

IARA

227 enrolled

Breast Neoplasms

NCT07373990 2026-01-28

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

418 enrolled

Nasopharyngeal Neoplasms

NCT07286162 2026-01-27

CALM-TF

300 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT07355283 2026-01-27

IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma

198 enrolled

Lymphoid

Lymphoma, Follicular

NCT07362836 2026-01-23

Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS)

224 enrolled

Colorectal Neoplasms

NCT07357298 2026-01-22

Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer

156 enrolled

Breast Neoplasms

NCT07346053 2026-01-16

Chrono-EVP

224 enrolled

Genitourinary

Advanced Bladder Cancer

NCT07289646 2026-01-14

Pegasus 2

418 enrolled

Thoracic

Disease, Lung Neoplasms

NCT07338981 2026-01-14

The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.

142 enrolled

Genitourinary

Advanced Kidney Cancer

NCT07336953 2026-01-13

A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)

198 enrolled

PDAC - Pancreatic Ductal Adenocarcinoma

NCT07331454 2026-01-12

Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer

335 enrolled

Stomach Neoplasms

NCT07329634 2026-01-09

RENESANS

98 enrolled

Brain Neoplasms

NCT07320690 2026-01-06

Neo-Margin

356 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT07314203 2026-01-02

SOP-XH-IRB

118 enrolled

Stomach Neoplasms

NCT07300514 2025-12-23

T-START-M1

136 enrolled

Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

NCT07287592 2025-12-17

Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.

70 enrolled

Tumor-Agnostic

Neoplasms

NCT07284394 2025-12-16

PACHA-02

272 enrolled